Biography

Mark L. Baum is the founder, Chairman of the Board, and Chief Executive Officer of Harrow. Mr. Baum is a founder and former board member of Eton Pharmaceuticals (Nasdaq: ETON) and Surface Ophthalmics, as well as a founder and the current Chairman of the Board of Melt Pharmaceuticals. From 2014-2017, Mr. Baum was a senior advisor to Curology.com. Before Harrow, as the founder of TBLF, LLC, a private investment fund manager, Mr. Baum made more than 200 investments in, and provided advisory and board service to, more than 40 private and public companies. In 1999, Mr. Baum founded YesRx, an HIV-focused pharmacy business. Mr. Baum actively advocates for patient and physician pharmaceutical accessibility issues, including being featured in Op-Ed contributions for the Wall Street Journal and appearances on national and international media outlets and other forums. Mr. Baum was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Mr. Baum serves on the board of the Ophthalmology Foundation, which works with eye care professionals and professional societies to enhance and provide ophthalmic education, focusing on low-resource and underserved countries. Mr. Baum is a graduate, cum laude, of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.